Using a Gravimetric Feeder for Dosing Pharmaceutical Bulk Solids - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Using a Gravimetric Feeder for Dosing Pharmaceutical Bulk Solids
Loss-in-weight feeders provide high accuracy for feeding powders.

Equipment and Processing Report

Bulk-solids feeders are devices that meter the flow of bulk solids (e.g., powders) from a source (e.g., storage hoppers, intermediate bulk containers) to the downstream process at a precise flow rate. The optimal feeder depends on the powder’s flow characteristics, as well as the precision and throughput needed. In the pharmaceutical industry, single or twin-screw, volumetric or gravimetric feeders are commonly used to meter powders in various processes, such as milling, granulation, coating, direct compression, and blending. Pharmaceutical Technology spoke to Sharon Nowak, global business development manager for Food and Pharmaceutical, K-Tron, to find out more about how gravimetric, loss-in-weight feeders can be used in pharmaceutical bulk-solids processing.

PharmTech: How do volumetric and gravimetric feeders differ?

Nowak: Volumetric feeders control flow by metering a constant volume per time by regulating the speed of the feeding device.  In the case of screw feeders, for example, this would include setting the screw speed. The required speed is calibrated by weighing a timed sample. It should be noted that although there is no feedback to assure feeding accuracy over time, this may not be a concern for certain applications or materials with consistent bulk density. For this reason, volumetric feeders can be an economical choice for free-flowing materials and batch processes that require a lower degree of accuracy.

Gravimetric feeders, on the other hand, are real-time devices that meter the rate at a constant weight per unit of time. Weight is measured using a load cell; a feedback loop regulates the speed of the feeding device to control the feeder’s accuracy. Gravimetric feeders as provided by K-Tron, for example, provide a much higher degree of accuracy, typically in the range of 0.25–0.5% of the required massflow setpoint.

PharmTech: Can you explain further how a gravimetric feeder works?

Nowak: The most popular type of gravimetric feeder used in continuous processes is the loss-in-weight feeder (see Figure 1).  Loss-in-weight feeders directly measure and control the process variable of flow rate and can fully contain the material within the confines of the feeder. Loss-in-weight feeders are typically either mounted on weigh scales or suspended from load cells. The K-Tron load cell, for example, is designed specifically for the rate and accuracy requirements of dynamic feeding and includes a resolution as high as 1:4,000,000.

A loss-in-weight feeder consists of a hopper and feeder that are isolated from the process so the entire system can be continuously weighed. As the feeder discharges material, system weight declines. The speed of the metering device is controlled to result in a per-unit-time loss of system weight equal to the desired feed rate. A typical loss-in-weight feeder controller adjusts feeder speed to produce a rate of weight loss equal to the desired feed rate setpoint.

Any changes in material bulk density are sensed and accounted for by a change in metering speed. Precision, digital load cells from K-Tron use vibrating-wire weighing technology and digital filtering to discriminate between weight data and environmental effects, such as temperature, ambient vibration, and shock (Smart Force Transducer, K-Tron).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Equipment and Processing Report,
Click here